We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.21% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3451
Aebi Schmidt Holding AG
AEBI
$885M
| $436K | ﹤0.01% |
34,746
-19,347
| -36% | -$229K |
2025 Q3
3 quarters
|
|
3452
Fidelity MSCI Health Care Index ETF
FHLC
$4.03B
| $436K | ﹤0.01% |
+5,640
| New | +$405K |
2026 Q2
0 quarters
|
|
3453
Vanguard Russell 2000 Value ETF
VTWV
$1.3B
| $435K | ﹤0.01% |
2,228
+389
| +21% | +$71.8K |
2025 Q3
3 quarters
|
|
3454
Prime Medicine
PRME
$780M
| $435K | ﹤0.01% |
117,998
-436,937
| -79% | -$1.45M |
2024 Q4
6 quarters
|
|
3455
WisdomTree International SmallCap Dividend Fund
DLS
$1.02B
| $435K | ﹤0.01% |
5,191
-210
| -4% | -$18.1K |
2026 Q1
1 quarter
|
|
3456
OneAscent Large Cap Core ETF
OALC
$275M
| $434K | ﹤0.01% |
+10,582
| New | +$413K |
2026 Q2
0 quarters
|
|
3457
Hagerty
HGTY
$2.08B
| $434K | ﹤0.01% |
36,414
+14,739
| +68% | +$158K |
2025 Q4
2 quarters
|
|
3458
NuScale Power
SMR
$2.23B
| $433K | ﹤0.01% |
43,148
+27,873
| +182% | +$314K |
2024 Q3
7 quarters
|
|
3459
Horizon Technology Finance
HRZN
$252M
| $432K | ﹤0.01% |
91,368
+58,350
| +177% | +$252K |
2024 Q4
6 quarters
|
|
3460
iShares iBonds Dec 2033 Term Treasury ETF
IBTO
$518M
| $430K | ﹤0.01% |
17,826
| – | – |
2025 Q3
3 quarters
|
|
3461
iShares 10-20 Year Treasury Bond ETF
TLH
$12.4B
| $430K | ﹤0.01% |
4,284
+1,496
| +54% | +$149K |
2025 Q4
2 quarters
|
|
3462
Carlyle Secured Lending
CGBD
$768M
| $428K | ﹤0.01% |
40,673
-518
| -1% | -$5.77K |
2025 Q4
2 quarters
|
|
3463
Immunovant
IMVT
$7.26B
| $427K | ﹤0.01% |
+11,082
| New | +$338K |
2026 Q2
0 quarters
|
|
3464
OPAL Fuels
OPAL
$43M
| $426K | ﹤0.01% |
193,801
+129,582
| +202% | +$285K |
2025 Q3
3 quarters
|
|
3465
Life360
LIF
$3.67B
| $425K | ﹤0.01% |
7,683
+698
| +10% | +$31K |
2025 Q3
3 quarters
|
|
3466
SEACOR Marine Holdings
SMHI
$249M
| $425K | ﹤0.01% |
+55,555
| New | +$412K |
2026 Q2
0 quarters
|
|
3467
RGC Resources
RGCO
$246M
| $424K | ﹤0.01% |
17,744
+7,673
| +76% | +$177K |
2025 Q3
3 quarters
|
|
3468
Terrestrial Energy
IMSR
$318M
| $423K | ﹤0.01% |
+59,777
| New | +$442K |
2026 Q2
0 quarters
|
|
3469
Medline Inc
MDLN
$35.8B
| $423K | ﹤0.01% |
+10,726
| New | +$432K |
2026 Q2
0 quarters
|
|
3470
Aris Mining
ARIS
$3.44B
| $422K | ﹤0.01% |
28,299
-11,118
| -28% | -$200K |
2026 Q1
1 quarter
|
|
3471
Vert Global Sustainable Real Estate ETF
VGSR
$512M
| $420K | ﹤0.01% |
36,900
-1,089
| -3% | -$12.2K |
2025 Q3
3 quarters
|
|
3472
National CineMedia
NCMI
$156M
| $420K | ﹤0.01% |
110,532
+53,938
| +95% | +$184K |
2024 Q3
7 quarters
|
|
3473
Baytex Energy
BTE
$2.86B
| $416K | ﹤0.01% |
103,800
-50,650
| -33% | -$234K |
2026 Q1
1 quarter
|
|
3474
Gencor Industries
GENC
$252M
| $416K | ﹤0.01% |
27,870
+5,712
| +26% | +$84.6K |
2025 Q2
4 quarters
|
|
3475
Abeona Therapeutics
ABEO
$145M
| $414K | ﹤0.01% |
67,063
-35,582
| -35% | -$195K |
2025 Q3
3 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.